Congress · 29. April 2019
SYnAbs, RD-Biotech, Diaclone & QVQ companies attend Knowledge 4 growth Congress on May 9th.
Technical breakthrough · 27. April 2019
Cell-adhesion molecules (CAMs) antibodies: cadherin antibodies, selection antibodies, integrin antibodies, Ig-like CAM
Congress · 25. April 2019
SYnAbs, RD-Biotech, Diaclone & QVQ attend Labvolution congress in Germany for custom bioproduction services
Technical breakthrough · 20. April 2019
SYnAbs and Univercells announce strategic agreement on biosimilar. Anti-idiotype generation, custom immuno-assay development & validation.
Congress · 19. April 2019
Meet mAb experts for therapeutic antibodies custom generation and manufacturing.
Technical breakthrough · 16. April 2019
Limits of immunization site against poor immunogenic antigen targets Gold standard in immunization procedures in animal Intraperitoneal (IP) and intravenous (IV) injections are well-established immunization procedures for raising mouse antibodies, and are considered as gold standard. But in the particular case of poor immunogenic compounds or haptens (like peptides, polysaccharides, lipids, small molecules…), traditional strategies can fail to generate large panels of mAbs and finally get a...
Technical breakthrough · 12. April 2019
Anti-rabies monoclonal antibody for potency testing of vaccines: replacing in-vivo test by in-vitro assay
